4SC AG INH. O.N./ DE000A3E5C40 /
2024-03-28 9:16:25 AM | Chg. 0.0000 | Volume | Bid9:16:26 AM | Ask9:30:20 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.7000EUR | 0.00% | 0 Turnover: 0.0000 |
8.7000Bid Size: 172 | 9.0500Ask Size: 60 | 87.99 mill.EUR | 0.00% | - |
GlobeNewswire
2023-12-05
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
2019-04-01
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
2018-06-11
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018